Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Derek Richard Shyr

Title
Institution
Department
Address

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Plant-Fox AS, Ma C, Al-Sayegh H, Shyr D, Lee MA, Lehmann LE, Chi SN. Comparison of toxicity following single versus tandem autologous transplant regimens for pediatric medulloblastoma. Pediatr Transplant. 2022 06; 26(4):e14229. PMID: 35083822.
    Citations:    Fields:    Translation:Humans
  2. McCabe SD, Hammershaimb EA, Cheng D, Shi A, Shyr D, Shen S, Cole LD, Cataldi JR, Allen W, Probasco R, Silbermann B, Zhang F, Marsh R, Travassos MA, Lin X. Unraveling Attributes of COVID-19 Vaccine Hesitancy and Uptake in the U.S.: A Large Nationwide Study. medRxiv. 2021 Jul 02. PMID: 33851172; PMCID: PMC8043469.
    Citations:    
  3. Shyr D, Shyr Y. The design and analysis of non-randomized studies: a case study of off-label use of hydroxychloroquine in the COVID-19 pandemic. Expert Opin Investig Drugs. 2021 Feb; 30(2):111-117. PMID: 33353432.
    Citations:    Fields:    Translation:HumansPHPublic Health
  4. Nait Saada J, Kalantzis G, Shyr D, Cooper F, Robinson M, Gusev A, Palamara PF. Identity-by-descent detection across 487,409 British samples reveals fine scale population structure and ultra-rare variant associations. Nat Commun. 2020 11 30; 11(1):6130. PMID: 33257650; PMCID: PMC7704644.
    Citations: 16     Fields:    Translation:Humans
  5. Shyr Y, Shyr D. What Constitutes a Valid Surrogate End Point in Cancer Clinical Trials? JAMA Oncol. 2020 09 01; 6(9):1334-1335. PMID: 32701117; PMCID: PMC7780730.
    Citations: 3     Fields:    Translation:Humans
  6. Campbell K, Shyr D, Bagatell R, Fischer M, Nakagawara A, Nieto AC, Brodeur GM, Matthay KK, London WB, DuBois SG. Comprehensive evaluation of context dependence of the prognostic impact of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project. Pediatr Blood Cancer. 2019 08; 66(8):e27819. PMID: 31115156.
    Citations: 6     Fields:    Translation:Humans
  7. Zheng DJ, Shyr D, Ma C, Muriel AC, Wolfe J, Bona K. Feasibility of systematic poverty screening in a pediatric oncology referral center. Pediatr Blood Cancer. 2018 12; 65(12):e27380. PMID: 30069999; PMCID: PMC6193823.
    Citations: 5     Fields:    Translation:Humans
  8. Shyr D, Liu Q. Next generation sequencing in cancer research and clinical application. Biol Proced Online. 2013 Feb 13; 15(1):4. PMID: 23406336; PMCID: PMC3599179.
    Citations: 40     
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: SPH faculty should contact Faculty Affairs at facultyaffairshsph.harvard.edu).
Shyr's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (47)
Explore
_
Co-Authors (9)
Explore
_
Similar People (59)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.